Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Eisana Corp
Profile last edited on: 6/17/2024      CAGE: 8HM61      UEI: LUW6W9WL7CX5

Business Identifier: An oncology solution company that provides tech-enabled solutions to prevent cancer treatment side effects
Year Founded
2020
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8350 Ashlane Way Suite 104
Spring, TX 77382
   (619) 693-7800
   info@eisana.com
   www.eisana.com
Location: Single
Congr. District: 02
County: Montgomery

Public Profile

Eisana is an oncology solution company that provides a platform for multiple products to address cancer treatment issues. They provide products like cooling devices to prevent nerve damage and hair loss during chemotherapy. They help cancer patients not only survive but also thrive.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$399,824
Phase II Dollars
$0
Total Awarded
$399,824

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
0 1 NIH $399,824
Project Title: Development and testing of a non-invasive cryo-device to prevent chemotherapy-induced peripheral neuropathy in hands and feet of cancer patients receiving Taxol for breast cancer.

Key People / Management

  Carole Spangler-Vaughn -- CEO, Founder, Inventor, Director

  Lisa Malina -- CFO

  Martin A Simonetti -- Board Chair

  Ann Tanabe -- Director

Company News

There are no news available.